Posted on 8/10/20
Actinium Pharmaceuticals Announces Reverse Stock Split
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) today announced that its Board of Directors approved a 1-for-30 reverse split of its issued and outstanding common stock that . . .
Posted on 8/10/20
Citius Pharmaceuticals Closes $9.6M Bought Deal Offering
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today the closing of its previously announced . . .
Posted on 8/10/20
Healthify Partners with Algorex
Healthify, a company that works with payers and providers to create social determinants of health (SDoH) infrastructures, today announced a partnership with healthcare data analytics company . . .
Posted on 8/10/20
UroGen Pharma Reports Second Quarter 2020 Financial Results and Recent Corporate Developments
PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced . . .
Posted on 8/10/20
Immunic Closes $103.5M Public Offering
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, announced the . . .
Posted on 8/10/20
TG Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial Results
NEW YORK, Aug. 10, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the second quarter ended June 30, 2020 . . .
Posted on 8/10/20
Intercept Pharmaceuticals Reports Second Quarter 2020 Financial Results
NEW YORK, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to . . .
Posted on 8/10/20
Amicus Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates
CRANBURY, N.J. , Aug. 10, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel medicines . . .
Posted on 8/10/20
PTC Therapeutics Looks Like A Better Value After Recent Pullback
SummaryPTC has continued to execute, and the company still showed modest sales growth despite the pandemic.Since my April article on the company, PTC has gotten risdiplam . . .
Posted on 8/10/20
Pfizer to Co-Manufacture Coronavirus Drug Remdesivir
Two pharmaceutical industry rivals are teaming up in the fight against SARS-CoV-2 and the disease it can cause, COVID-19. On Friday, Pfizer (NYSE:PFE) announced it had . . .
Posted on 8/10/20
Is Pfizer Stock a Buy?
The COVID-19 pandemic is creating many problems in the healthcare industry, from hospitals struggling to treat patients with the disease (and deferring elective procedures in the . . .
Posted on 8/10/20
This Could Be the Ace in the Hole for Johnson & Johnson's COVID-19 Vaccine
Six companies are currently evaluating COVID-19 vaccine candidates in late-stage testing. Johnson & Johnson (NYSE:JNJ) isn't one of them.J&J was among the first to commit resources . . .
Posted on 8/10/20
Why the Market Hates the Teladoc-Livongo Deal
A merger between two of the hottest stocks on the market may sound like a match made in heaven. But when one emerged recently, investors didn't . . .
Posted on 8/10/20
Is Teladoc a Top Stock to Buy Now?
Teladoc Health's (NYSE:TDOC) meteoric rise to prominence this year shows no sign of slowing, with the company reporting impressive positive results in its July 29 earnings . . .
Posted on 8/10/20
Is It Too Late to Buy Teladoc Stock?
With people staying at home as much as possible in this new era of social distancing, Teladoc Health (NYSE:TDOC) is seeing demand for its virtual care . . .
Posted on 8/10/20
Why Teladoc Stock Soared 25% in July but Is Down 19% in August
What happenedShares of telehealth leader Teladoc Health (NYSE:TDOC) surged 24.5% in July, according to data from S&P Global Market Intelligence. For context, the S&P 500 returned . . .
Posted on 8/9/20
Regeneron Prices Public Offering of Senior Unsecured Notes
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the pricing of an underwritten offering of $1.250 billion aggregate principal amount of senior unsecured notes due 2030 and . . .
Posted on 8/9/20
Cellectis Provides Business Update
NEW YORK (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on allogeneic gene-edited CAR T-cells . . .
Posted on 8/7/20
Pfizer Announces Agreement with Gilead
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of . . .
Posted on 8/7/20
Biohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 Million
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) and Royalty Pharma (Nasdaq: RPRX) announced today that Biohaven has secured up to $250 million in funding to advance . . .
Posted on 8/7/20
Biohaven Announces up to $500 Million Non-Dilutive Term Loan with Sixth Street
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) announced that it entered into a $500 million non-dilutive term loan financing facility with Sixth Street, a leading global . . .
Posted on 8/7/20
Lodo Therapeutics Acquires Conifer Point Pharmaceuticals
Lodo Therapeutics Corp. (Lodo), a biotechnology company reinventing natural product drug discovery by applying its informatics-enabled technology platform to previously undruggable disease targets, today announced that . . .
Posted on 8/7/20
Pfizer, Merck, and Others See a Slowdown in Vaccine Sales, but Anticipate an Autumn Rebound
With all the news and chatter about coronavirus vaccine candidates these days, it might be somewhat surprising to learn that sales of established vaccines have been . . .
Posted on 8/6/20
Celldex Provides Corporate Update
HAMPTON, N.J., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the second quarter ended June 30, 2020. . . .
Posted on 8/6/20
Interview with Guy D’Andrea, Founder and Managing Partner of Discern Health
As all aspects of healthcare continue to evolve amidst the COVID-19 pandemic, there remains an opportunity for companies to provide an integrated approach across the health . . .
New York
